“NON-PROFIT ORGANIZATION”

representing members who are research based pharmaceutical companies innovating medicines to combat the previously incurable and to improve on existing treatments.

Who is PReMA?


NON-PROFIT ORGANIZATION representing members who are research based pharmaceutical companies innovating medicines to combat the previously incurable and to improve on existing treatments.+ see more

Knowledge Center

 

Crack the Mindset: A journey to be an innovator The word “Innovation” is mostly been taken in a very complicated and hard to reach aspect.     
                                                                                          + see more

PReMA News

 

To commemorate International Women’s Day, Organon International is collaborating with various sectors to support the Smart Family policy.
                                                                                      + see more

How are new drugs discovered?

Developing a new medicine begins with understanding the disease or condition as
thoroughly as possible. Basic research provides clues about how to
treat diseases and potential ways to target the symptoms or underlying causes.
Researchers work to understand biological targets of the drug they want to develop which can be protein,
RNA, DNA, and other molecule that is related to the disease. The researcher work to discover a lead compound which is
a promising molecule that could influence target and has a potential to be developed into a medicine.

Understand disease mechanisms.

Conduct basic research to obtain clues and treatment options.

Understand the biological targets of drugs.

Develop a drug from a lead compound, a molecule that will affect biological targets. And there is a possibility that it will develop into a drug.

PReMA Members